Ellipsys Vascular Access System Registry

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

April 17, 2019

Study Completion Date

July 30, 2020

Conditions
End-stage Renal Disease
Interventions
DEVICE

Ellipsys Vascular Access

The Ellipsys Vascular Access System comprises the Ellipsys Catheter, Ellipsys Crossing Needle and Ellipsys Power Controller. The Ellipsys Crossing Needle is used to facilitate access between the artery and the vein. The Ellipsys Catheter is placed percutaneously into the selected vein in close proximity to the selected artery. The Ellipsys Catheter is actuated at the selected anastomosis site, and the vein and artery are approximated. Once the vessels are in the appropriate relative positions the catheter is connected to the Ellipsys Power Controller to create the anastomosis after which the Ellipsys Catheter is removed, and the access site is closed using standard percutaneous closure techniques.

Trial Locations (5)

26655

Ammerland Klinik, Westerstede

48149

Universitätsklinikum Münster, Münster

66111

Universitätsklinikum des Saarlandes, Saarbrücken

79189

Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen

Unknown

Universitätsklinikum Düsseldorf, Düsseldorf

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT03454113 - Ellipsys Vascular Access System Registry | Biotech Hunter | Biotech Hunter